Applications of Sleeping Beauty transposons for nonviral gene therapy

IUBMB Life

Volumn 59, Issue 6, 2007, Pages 374-379

  Liu, Hanzhong ^a   Visner, Gary A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Nonviral gene therapy; Transposase; Transposon

Indexed keywords

GENE PRODUCT; PLASMID DNA; POLYETHYLENEIMINE; SLEEPING BEAUTY PROTEIN; TRANSPOSASE; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; CHROMOSOMAL INSTABILITY; DNA BINDING; DNA TRANSPOSITION; GENE EXPRESSION; GENE STRUCTURE; GENE VECTOR; GLIOBLASTOMA; HEMOPHILIA A; HUMAN; LONG TERM CARE; LUNG DISEASE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PROTEIN DOMAIN; REVIEW; TRANSPOSON; TYROSINEMIA;

DNA TRANSPOSABLE ELEMENTS; GENE THERAPY; GENETIC VECTORS; HUMANS; TRANSPOSASES;

EID: 34347375914     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540701435722     Document Type: Review

References (32)

1. Thomas, C. E., Ehrhardt, A., and Kay, M. A. (2003) Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346-358.
2. Dave, U. P., Jenkins, N. A., and Copeland, N. G. (2004) Gene therapy insertional mutagenesis insights. Science 303, 333.
3. Glover, D.J., Lipps, H.J., and Jans, D. A. (2005) Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 6, 299-310.
4. Liu, L., Mah, C., and Fletcher, B. S. (2006) Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon. Mol. Ther. 13, 1006-1015.
5. Liu, L., Liu, H., Visner, G., and Fletcher, B. S. (2006) Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. Faseb J. 20, 2594-2596.
6. Liu, H., Liu, L., Fletcher, B. S., and Visner, G. A. (2006) Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. Faseb J. 20, 2384-2386.
7. Ivics, Z., Hackett, P. B., Plasterk, R. H., and Izsvak, Z. (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501-510.
8. Izsvak, Z., Khare, D., Behlke, J., Heinemann, U., Plasterk, R. H., and Ivics, Z. (2002) Involvement of a bifunctional, paired-like DNA-binding domain and a transpositional enhancer in Sleeping Beauty transposition. J. Biol. Chem. 277, 34581-34588.
9. Cui, Z., Geurts, A. M., Liu, G., Kaufman, C. D., and Hackett, P. B. (2002) Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon. J. Mol. Biol. 318, 1221-1235.
10. Zayed, H., Izsvak, Z., Walisko, O., and Ivics, Z. (2004) Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol. Ther. 9, 292-304.
11. Geurts, A. M., Yang, Y., Clark, K. J., Liu, G., Cui, Z., Dupuy, A. J., Bell, J. B., Largaespada, D. A., and Hackett, P. B. (2003) Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol. Ther. 8, 108-117.
12. Ivics, Z., Izsvak, Z., Minter, A., and Hackett, P. B. (1996) Identification of functional domains and evolution of Tc1-like transposable elements. Proc. Natl. Acad. Sci. USA 93, 5008-5013.
13. Lohe, A. R., De Aguiar, D., and Hartl, D. L. (1997) Mutations in the mariner transposase: the D,D(35)E consensus sequence is nonfunctional. Proc. Natl. Acad. Sci. USA 94, 1293-1297.
14. Doak, T. G., Doerder, F. P., Jahn, C. L., and Herrick, G. (1994) A proposed superfamily of transposase genes: transposon-like elements in ciliated protozoa and a common 'D35E' motif. Proc. Natl. Acad. Sci. USA 91, 942-946.
15. Junop, M. S., and Haniford, D. B. (1997) Factors responsible for target site selection in Tn10 transposition: a role for the DDE motif in target DNA capture. Embo J. 16, 2646-2655.
16. Baus, J., Liu, L., Heggestad, A. D., Sanz, S., and Fletcher, B. S. (2005) Hyperactive transposase mutants of the sleeping beauty transposon. Mol. Ther. 12, 1148-1156.
17. Izsvak, Z., and Ivics, Z. (2004) Sleeping Beauty transposition: biology and applications for molecular therapy. Mol. Ther. 9, 147-156.
18. Yusa, K., Takeda, J., and Horie, K. (2004) Enhancement of sleeping beauty transposition by CpG methylation: possible role of heterochromatin formation. Mol. Cell. Biol. 24, 4004-4018.
19. Ikeda, R., Kokubu, C., Yusa, K., Keng, V. W., Horie, K., and Takeda, J. (2007) Sleeping Beauty transposase has an affinity for heterochromatin conformation. Mol. Cell. Biol. 27, 1665-1676.
20. Yant, S. R., Meuse, L., Chiu, W., Ivics, Z., Izsvak, Z., and Kay, M. A. (2000) Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25, 35-41.
21. Montini, E., Held, P. K., Noll, M., Morcinek, N., Al-Dhalimy, M., Finegold, M., Yant, S. R., Kay, M. A., and Grompe, M. (2002) In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol. Ther. 6, 759-769.
22. Ohlfest, J. R., Frandsen, J. L., Fritz, S., Lobitz, P. D., Perkinson, S. G., Clark, K. J., Nelsestuen, G., Key, N. S., McIvor, R. S., Hackett, P. B., and Largaespada, D. A. (2005) Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 105, 2691-2698.
23. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297-7301.
24. Li, S., Tan, Y., Viroonchatapan, E., Pitt, B. R., and Huang, L. (2000) Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L504-511.
25. Ohlfest, J. R., Demorest, Z. L., Motooka, Y., Vengco, I., Oh, S., Chen, E., Scappaticci, F. A., Saplis, R. J., Ekker, S. C., Low, W. C., Freese, A. B., and Largaespada, D. A. (2005) Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. Mol. Ther. 12, 778-788.
26. Kawakami, S., Ito, Y., Charoensit, P., Yamashita, F., and Hashida, M. (2006) Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J. Pharmacol. Exp. Ther. 317, 1382-1390.
27. Nakai, H., Montini, E., Fuess, S., Storm, T. A., Grompe, M., and Kay, M. A. (2003) AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34, 297-302.
28. Zhu, Y., Dai, J., Fuerst, P. G., and Voytas, D. F. (2003) Controlling integration specificity of a yeast retrotransposon. Proc. Natl. Acad. Sci. USA 100, 5891-5895.
29. Krieg, A. M. (2002) CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760.
30. Zayed, H., Izsvak, Z., Khare, D., Heinemann, U., and Ivics, Z. (2003) The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res. 31, 2313-2322.
31. Wu, S. C., Meir, Y. J., Coates, C. J., Handler, A. M., Pelczar, P., Moisyadi, S., and Kaminski, J. M. (2006) PiggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc. Natl. Acad. Sci. USA 10, 15008-15013.
32. Balciunas, D., Wangensteen, K. J., Wilber, A., Bell, J., Geurts, A., Sivasubbu, S., Wang, X., Hackett, P. B., Largaespada, D. A., McIvor, R. S., and Ekker, S. C. (2006) Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLos Genet. 2, el69, 1715-1724.